These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11023520)

  • 1. Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.
    Annunziata CM; Safiran YJ; Irving SG; Kasid UN; Cossman J
    Blood; 2000 Oct; 96(8):2841-8. PubMed ID: 11023520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.
    Zheng B; Georgakis GV; Li Y; Bharti A; McConkey D; Aggarwal BB; Younes A
    Clin Cancer Res; 2004 May; 10(9):3207-15. PubMed ID: 15131062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
    Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
    Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
    Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
    Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.
    Mathas S; Hinz M; Anagnostopoulos I; Krappmann D; Lietz A; Jundt F; Bommert K; Mechta-Grigoriou F; Stein H; Dörken B; Scheidereit C
    EMBO J; 2002 Aug; 21(15):4104-13. PubMed ID: 12145210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
    Hinz M; Löser P; Mathas S; Krappmann D; Dörken B; Scheidereit C
    Blood; 2001 May; 97(9):2798-807. PubMed ID: 11313274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.
    Emmerich F; Meiser M; Hummel M; Demel G; Foss HD; Jundt F; Mathas S; Krappmann D; Scheidereit C; Stein H; Dörken B
    Blood; 1999 Nov; 94(9):3129-34. PubMed ID: 10556199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines.
    Holz MS; Janning A; Renné C; Gattenlöhner S; Spieker T; Bräuninger A
    Mol Cancer Ther; 2013 Feb; 12(2):173-83. PubMed ID: 23243060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
    Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP.
    Baccam M; Woo SY; Vinson C; Bishop GA
    J Immunol; 2003 Mar; 170(6):3099-108. PubMed ID: 12626566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
    Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
    Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs.
    Kashkar H; Deggerich A; Seeger JM; Yazdanpanah B; Wiegmann K; Haubert D; Pongratz C; Krönke M
    Blood; 2007 May; 109(9):3982-8. PubMed ID: 17185461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
    Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis.
    Zazzeroni F; Papa S; Algeciras-Schimnich A; Alvarez K; Melis T; Bubici C; Majewski N; Hay N; De Smaele E; Peter ME; Franzoso G
    Blood; 2003 Nov; 102(9):3270-9. PubMed ID: 12855571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.